Skip to content

An open, single arm clinical trial to evaluate the safety and efficacy of cochlear implant in the treatment of severe to profound sensorineural deafness in both ears

An open, single arm clinical trial to evaluate the safety and efficacy of cochlear implant in the treatment of severe to profound sensorineural deafness in both ears

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082071
Enrollment
Unknown
Registered
2024-03-20
Start date
2020-10-19
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe to profound sensorineural deafness in both ears

Interventions

experimental group:cochlear implant

Sponsors

Hainan Boao Super Hospital Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) For patients aged 12 months or above; 2) Binaural severe or profound sensorineural deafness; 3) The subjects can understand the purpose of the study, voluntarily participate in and sign the informed consent; 4) The subjects are willing to complete the follow up and evaluation according to the requirements of the protocol.

Exclusion criteria

Exclusion criteria: 1) Deafness caused by damage to auditory nerve or central auditory channel; 2) Active inflammation of the outer or middle ear; 3) Cochlea ossification, which cannot be implanted with electrodes; 4) Incomplete cochlea development; 5) Tympanic membrane perforation caused by recurrent otitis media; 6) Patients with mental disorders or mental retardation; 7) Patients who were not considered suitable for this study by the investigator.

Design outcomes

Primary

MeasureTime frame
The hearing threshold with CI in sound field (0.5, 1.0, 2.0 and 4.0 kHz);The verbal recognition rate of open monosyllabic words, two-syllable and short sentences in quiet environment;Subjective questionnaire: ITMAIS for patients under 3 years old (excluding 3 years); MAIS for those aged 3-6 years (including 3 years);

Secondary

MeasureTime frame
20% improvement in verbal recognition rate compared with preoperative level using hearing aid;Doctors’ evaluation of the performance of cochlear implants, such as implant thickness, electrode flexibility, easiness of implantation, and electrode vulnerability and so on.;The incidence of adverse events or complications;

Countries

China

Contacts

Public ContactJing Zhang

Hainan Boao Super Hospital Co., Ltd.

1014280858@qq.com+86 138 9988 0909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026